Ascendis Pharma A/s share price logo

Ascendis Pharma A/s Share Price

NASDAQ: ASND

Large Cap

$221.94

-1.88

(-0.84%)

as on

Ascendis Pharma A/s Stock Performance

as on March 21, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $221.52
    $226.19
    downward going graph

    0.19%

    Downside

    1.91%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $124.06
    $248.60
    downward going graph

    44.10%

    Downside

    12.01%

    Upside

    downward going graph

Ascendis Pharma A/s share price movements today

Previous Close
$223.82
Open
$224.00
Volume
379.8K
Day's Low - High
$221.52 - $226.19
52 Week Low - High
$124.06 - $248.60

Ascendis Pharma A/s Historical Returns

1 Month Return
-0.52 %
3 Month Return
+ 11.92 %
1 Year Return
+ 37.11 %
3 Year Return
+ 103.84 %
5 Year Return
+ 54.89 %

Ascendis Pharma A/s Stock Fundamentals & Key Indicators

Check Ascendis Pharma A/s market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$14.0B

EPS (TTM)

4.556

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-131.4M

Revenue (TTM)

720.1M

Profit Margin

-31.67%

Return On Equity TTM

-818.43%

Ascendis Pharma A/s vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ascendis Pharma A/s with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Ascendis Pharma A/s image
Ascendis Pharma A/s
BUY$14.0B54.89%NA-31.67%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.7B115.8%135.118.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$114.7B111.95%29.532.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$32.4BNA114.755.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$78.7B55.68%17.9531.41%

Stock Returns calculator for Ascendis Pharma A/s Stock including INR - Dollar returns

The Ascendis Pharma A/s stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ascendis Pharma A/s investment value today

Current value as on today

₹1,44,506

Returns

₹44,506

(+44.51%)

Returns from Ascendis Pharma A/s Stock

₹35,959 (+35.96%)

Dollar Returns*

₹8,546 (+8.55%)

Analyst Recommendation on Ascendis Pharma A/s Stock

Based on 20 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 20 analysts, 80% of analysts recommend a 'BUY' rating for Ascendis Pharma A/s. Average target price of $286.91

Ascendis Pharma A/s Share Price Target

Get share price movements and forecasts by analysts on Ascendis Pharma A/s.

What analysts predicted

22.64%UPSIDE

Target Price

$286.91

Current Price

$221.94

Analyzed by

20 Analysts

Target

$286.91

Ascendis Pharma A/s target price $286.91, a slight upside of 22.64% compared to current price of $221.94. According to 20 analysts rating.

Ascendis Pharma A/s Stock’s Investor Sentiment and Interest

Search interest for Ascendis Pharma A/s Stock has increased by 52% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:52% versus previous 30 day period

Ascendis Pharma A/s Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
51
150
104
35
57
181
100
158
213
245
Gross Profit
43
128
96
24
46
167
83
126
191
217
Operating Income
-134
-36
-49
-133
-96
0
-104
-52
10
9
EBITDA
-132
-67
-46
-87
-71
-37
-44
2
-53
14
Interest Expense
24
68
77
19
25
56
44
33
19
61
Depreciation
4
4
4
4
1
4
4
4
4
4
Income Before Tax
-161
-81
-128
-109
-98
-37
-93
-35
-57
-26
Income Tax Expense
0
5
2
0
1
1
1
3
3
6
Net Income
-173
-94
-142
-109
-99
-40
-94
-38
-60
-33
Net Profit Margin
-337.73%
-63.09%
-136.65%
-303.85%
-171.52%
-22.12%
-93.73%
-24.58%
-28.55%
-13.56%

Ascendis Pharma A/s Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
4
1
12
14
8
8
54
290
380
691
Gross Profit
4
1
12
14
8
4
41
242
334
588
Operating Income
-72
-111
-154
-226
-330
-451
-561
-455
-278
-130
EBITDA
-72
-109
-150
-210
-407
-364
-529
-411
-290
-113
Interest Expense
0
0
0
1
1
3
30
44
65
77
Depreciation
-
0
0
6
9
15
17
18
17
17
Income Before Tax
-68
-124
-130
-218
-419
-383
-577
-474
-373
-204
Income Tax Expense
0
0
0
0
0
0
5
7
4
14
Net Income
-72
-146
-147
-242
-509
-433
-617
-525
-395
-219
Net Profit Margin
-1487.30%
-8097.84%
-1229.53%
-1630.03%
-6025.53%
-4931.56%
-1139.63%
-180.51%
-103.97%
-31.67%

Ascendis Pharma A/s Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-86
-131
-109
-99
-38
-94
-38
-60
-33
Operating Cash Flow
-42
-101
-61
-56
-87
-14
-7
2
70
Investing Cash Flow
6
7
0
0
0
0
-4
0
-3
Financing Cash Flow
-6
18
-2
427
0
-18
6
38
8
Change in Cash
-49
-71
-61
366
-65
-41
-23
45
76

Ascendis Pharma A/s Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-123
-130
-218
-418
-383
-583
-481
-378
-219
Operating Cash Flow
-95
-138
-175
-271
-417
-495
-467
-306
51
Investing Cash Flow
0
-2
-5
-291
-110
61
286
6
-8
Financing Cash Flow
124
203
493
602
351
396
134
443
34
Change in Cash
15
82
320
-13
-138
-1
-52
167
122

Global Institutional Holdings in Ascendis Pharma A/s

Funds
Holdings
FMR Inc
6.77%
Amvescap Plc.
1.5%
Principal Financial Group Inc
1.29%
Artisan Partners Limited Partnership
5.25%
The Goldman Sachs Group Inc
1.06%
See all

Insights on Ascendis Pharma A/s

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 100.95M → 245.17M (in $), with an average increase of 25.0% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, ASND stock has moved up by 11.9%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -60.98M → -33.24M (in $), with an average increase of 83.4% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ASND has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ASND has outperformed top 5 stocks with highest market-cap in its industry

About Ascendis Pharma A/s

ascendis pharma a/s is a biotechnology company located in 12 tuborg blvd., hellerup, capital region of denmark, denmark.
OrganisationAscendis Pharma A/s
HeadquartersTuborg Boulevard 12, Hellerup, Denmark, 2900
IndustryHealth Technology
CEOMr. Jan Moller Mikkelsen
E-voting on sharesClick here to vote

Key Management of Ascendis Pharma A/s

Name

Title

Mr. Jan Moller Mikkelsen

President, CEO, Member of Executive Board & Executive Director

Mr. Chad Fugure

Vice President of Investor Relations

Mr. Joseph Kelly

Head of U.S. Commercial of Endocrinology

Mr. Flemming Steen Jensen

Executive Vice President of Product Supply & Quality

Dr. Kennett Sprogoe Ph.D.

Executive VP and Head of Research & Product Development

Dr. Stina Singel M.D., Ph.D.

Executive VP & Head of Clinical Development for Oncology

Mr. Scott T. Smith

CFO, Executive VP & Member of Executive Board

Ms. Pedersen Anni Lotte Kirstine Sonderbjerg

Executive VP, Chief Administrative Officer & Member of the Executive Board

Mr. Michael Wolff Jensen L.L.M.

Executive VP, Chief Legal Officer & Member of the Executive Board

Mr. Mads Bodenhoff

Senior VP, Head of Finance & Principal Accounting Officer

FAQs

What is Ascendis Pharma A/s share price today?

Ascendis Pharma A/s share price today is $221.94 as on at the close of the market. Ascendis Pharma A/s share today touched a day high of $226.19 and a low of $221.52.

What is the 52 week high and 52 week low for Ascendis Pharma A/s share?

Ascendis Pharma A/s share touched a 52 week high of $248.6 on and a 52 week low of $124.06 on . Ascendis Pharma A/s stock price today i.e. is closed at $221.94,which is 10.72% down from its 52 week high and 78.90% up from its 52 week low.

What is Ascendis Pharma A/s's market capitalisation today?

Ascendis Pharma A/s market capitalisation is $0.01T as on .

How to invest in Ascendis Pharma A/s Stock (ASND) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Ascendis Pharma A/s on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ascendis Pharma A/s Shares that will get you 0.0068 shares as per Ascendis Pharma A/s share price of $221.94 per share as on March 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy Ascendis Pharma A/s Stock (ASND) from India?

Indian investors can start investing in Ascendis Pharma A/s (ASND) shares with as little as ₹93.708 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.08 in Ascendis Pharma A/s stock (as per the Rupee-Dollar exchange rate as on ). Based on Ascendis Pharma A/s share’s latest price of $221.94 as on March 21, 2026 at 1:29 am IST, you will get 0.0451 shares of Ascendis Pharma A/s. Learn more about fractional shares .

What are the returns that Ascendis Pharma A/s has given to Indian investors in the last 5 years?

Ascendis Pharma A/s stock has given 54.89% share price returns and 27.65% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?